ReviewPharmaceutics2022

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review.

Alix Démaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.